Koers CSAM Health Group AS Oslo Bors
Aandelen
NO0010894512
Geavanceerde medische apparatuur & technologie
Omzet 2024 * | 454 mln. 41,66 mln. 38,77 mln. | Omzet 2025 * | 488 mln. 44,79 mln. 41,68 mln. | Marktkapitalisatie | 698 mln. 64,05 mln. 59,61 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 9 mln. 825K 768K | Nettowinst (verlies) 2025 * | 23 mln. 2,11 mln. 1,96 mln. | EV/omzet 2024 * | 2,3 x |
Nettoschuld 2024 * | 345 mln. 31,66 mln. 29,46 mln. | Nettoschuld 2025 * | 310 mln. 28,44 mln. 26,47 mln. | EV/omzet 2025 * | 2,07 x |
K/w-verhouding 2024 * |
78,4
x | K/w-verhouding 2025 * |
31,4
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 57,99% |
Recentste transcriptie over CSAM Health Group AS
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Sverre Flatby
CEO | Chief Executive Officer | - | - |
Director of Finance/CFO | - | - | |
Leif Egil Buen
COO | Chief Operating Officer | - | 01-11-14 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chairman | 72 | - | |
Director/Board Member | 64 | - | |
Director/Board Member | 61 | 01-01-22 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+4,84% | 33,18 mld. | |
+21,35% | 7,81 mld. | |
+25,15% | 3,98 mld. | |
-16,83% | 3,17 mld. | |
-20,32% | 1,39 mld. | |
-30,40% | 1,2 mld. | |
+7,35% | 970 mln. | |
-34,66% | 950 mln. | |
-27,55% | 808 mln. |